Some medical researchers say 7-OH products made from kratom extracts could have the potential to create addiction problems, ...

GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

The FDA's 2022 ban on Juul's four varieties of tobacco and menthol-flavored pods and the e-cigarette device was stayed a month later after an appeal by the company and rescinded in 2024.

Officials with the Food and Drug Administration have approved the continued sales of tobacco-flavored e-cigarettes and refill cartridges by Juul Labs.

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older against fleas and ticks.

The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering evergreen, for use in a variety of drinks and candies.

The Food and Drug Administration (FDA) has approved a new dosing regimen for Elrexfio ™ (elranatamab-bcmm) allowing certain patients with relapsed or refractory (R/R) multiple myeloma to receive ...

WASHINGTON — The US Food and Drug Administration has approved gardenia (genipin) blue color for use in certain foods and beverages, making it the fourth color derived from natural sources to be ...

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster vaccine for adult patients.

The FDA’s 2022 ban on Juul’s four varieties of tobacco and menthol-flavored pods and the e-cigarette device was stayed a month later after an appeal by the company.